Tumor necrosis factor (TNF)-␣ has been reported to modulate brain injury, but remarkably, little is known about its effects on neurogenesis. We report that TNF-␣ strongly influences survival, proliferation, and neuronal differentiation in cultured subventricular zone (SVZ) neural stem/progenitor cells derived from the neonatal P1-3 C57BL/6 mice. By using single-cell calcium imaging, we 
INTRODUCTION
In the adult brain, neurogenesis occurs constitutively in two defined regions: the subgranular zone of the hippocampus and the subventricular zone (SVZ) lining the lateral ventricles. Neural stem cells (NSCs) located in the SVZ proliferate and give rise to neuroblasts that migrate toward the olfactory bulb, where they differentiate into interneurons [1] [2] [3] [4] [5] . This robust process, giving rise to a constant neuronal replacement of olfactory interneurons, highlights the potential of SVZ cells for future stem cell-based brain repair strategies. Upon brain injury, newly generated neuroblasts migrate out of the SVZ toward the damaged areas of the brain [6 -12] . Injury-enhanced neurogenesis relies in part on soluble mediators released by damaged tissue and activated immune cells. In particular, inflammatory cytokines, abundantly secreted following brain injury or infection, may influence neurogenesis [13] [14] [15] [16] . Among these inflammatory mediators, tumor necrosis factor (TNF)-␣ is a crucial effector of immune responses in the brain [17, 18] , mediating distinct cellular effects through two different receptors: tumor necrosis factor receptor (TNFR) 1, which contains an intracellular "death domain" and contributes mainly to neuronal death, and TNFR2, which contributes mainly to neuroprotection [19 -22] . Recent reports suggest that TNF-␣ can also modulate neurogenesis. Indeed, neural stem/progenitor cells express TNF-␣ [23, 24] and its receptors [24 -28] .
It has been reported that TNF-␣ regulates survival of NSCs. However, recent studies have shown that TNF-␣ contributes to the death of hippocampal progenitor cells [26] and mousederived SVZ neurospheres in vitro [29] . In contrast, few apoptotic cells were found in the SVZ of TNF-␣-treated rats, where an increase in proliferation was observed in vivo in basal conditions [30] . Moreover, in vivo infusion of a neutralizing antibody against TNF-␣ reduced the number of new striatal and hippocampal neuroblasts generated after stroke [31] .
Several lines of evidence have also implicated TNF-␣ in proliferation of NSCs in the intact and in the injured brain. In particular, it has been shown that mice lacking TNF-␣ had a significant reduction of the pool of proliferating oligodendrocytes and a subsequent delay in remyelination in a mouse model of demyelinating diseases [32] . Furthermore, Widera et al. [28] showed that nuclear factor B and cyclin D1 play a crucial role in the proliferation of NSCs induced by TNF-␣ in vitro. However, TNF-␣ was found to inhibit proliferation of TNFR1-expressing striatal neural progenitors in vitro [25] . In accordance, by using mice lacking TNF-␣ receptors, Iosif et al. showed that TNFR1 acts as a suppressor of progenitor proliferation both under basal conditions and after onset of status epilepticus, whereas TNFR2 can improve survival of the newly formed neurons in the pathological brain in vivo [24] . Moreover, TNF-␣ was shown to stimulate neuronal differentiation of immature neural cells and neuroblastoma cell lines infected with HIV-1 [33, 34] .
In the present report, we dissect the effects of TNF-␣ on neurogenesis in mouse SVZ cultures by using a novel method able to functionally discriminate neuronal differentiation. Moreover, we investigated the involvement of the stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK) signaling pathway in response to TNF-␣ exposure and the interplay between cell death and proliferation. Taken together, our results open a new perspective for TNF-␣ as a proneurogenic factor, able to facilitate neuronal replacement and brain repair in response to brain injury.
MATERIALS AND METHODS
All experiments were performed in accordance with European Union (86/609/EEC) guidelines for the care and use of laboratory animals.
Subventricular Zone Cell Cultures
SVZ cells were prepared from 1-3-day-old C57BL/6 donor mice as described by Agasse et al. [35] . Briefly, mice were killed by decapitation, and the brains were removed and placed in calciumand magnesium-free Hanks' balanced saline solution (Gibco, Rockville, MD, http://www.invitrogen.com) under sterile conditions. Fragments of SVZ were dissected out of 450-m-thick coronal brain sections by using a McIlwain tissue chopper, and then SVZ was digested in 0.025% trypsin (Gibco) and 0.265 mM EDTA (Gibco) (10 minutes, 37°C), following by mechanical dissociation with a P1000 pipette. The cell suspension was diluted in serum-free medium (SFM) composed of Dulbecco's modified Eagle's medium (DMEM) (DMEM/Ham's F-12 medium ϩ GlutaMAX-I) supplemented with 100 U/ml penicillin, 100 g/ml streptomycin, 1% B27 supplement, 10 ng/ml epidermal growth factor, and 10 ng/ml basic fibroblast growth factor-2 (all from Gibco). Single cells were then plated on uncoated Petri dishes at a density of 3,000 cells per cm 2 and were allowed to develop in an incubator with 5% CO 2 and 95% atmospheric air at 37°C.
Six to 8 days after plating, the SVZ neurospheres were collected and seeded onto poly-D-lysine (0.1 mg/ml)-coated glass coverslips, placed into 12-well cell culture plates for single-cell calcium imaging (SCCI) experiments or 24-well cell culture plates for immunocytochemistry, and covered with 1 ml or 500 l, respectively, of SFM devoid of growth factors. Then, SVZ neurospheres were allowed to develop for 2 days with 5% CO 2 and 95% atmospheric air at 37°C before experimental treatments. A scheme of the protocol is provided in Figure 2A .
Experimental Treatments
To investigate the influence of TNF-␣ on neuronal differentiation, SVZ neurospheres were allowed to develop for 7 days with recombinant mouse (0.3, 1, 10, and 100 ng/ml; R&D Systems Inc., London, http://www.rndsystems.com) or human (1 ng/ml; Peprotech, London, http://www.peprotech.com) TNF-␣ at 37°C. To determine which TNF-␣ receptor was involved in the proneurogenic effect, SVZ cells were treated with 1 ng/ml mouse TNF-␣ together with 20 g/ml neutralizing mouse monoclonal anti-TNFR1 or with 20 g/ml neutralizing mouse monoclonal anti-TNFR2 antibodies [36] (both from R&D Systems). In a group of experiments, SVZ cells were treated with a neutralizing antibody against TNF-␣ (81 g/ml; Upstate Biotechnology, Lake Placid, NY, http://www. upstate.com). At the end of treatments, SCCI experiments and immunocytochemistry for neuronal markers (neuronal nuclear protein [NeuN] and microtubule associated protein-2 [MAP-2]) were performed ( Fig. 2A) . To dissociate the apoptotic effect of TNF-␣, SVZ cells were coincubated for 48 hours with 10 ng/ml TNF-␣ and 25 M z-Val-Ala-DL-Asp (OMe)-fluoromethylketone (zVAD-fmk; Calbiochem, Nottingham, U.K., http://www.emdbiosciences.com), a pan-caspase inhibitor used as an antiapoptotic agent.
To investigate the involvement of the SAPK/JNK signaling pathway in response to TNF-␣ stimulation, SVZ neurospheres were treated with 1, 10, or 100 ng/ml mouse recombinant TNF-␣ for 15 minutes or 6 hours at 37°C. At the end of each incubation protocol, immunocytochemistry against phosphorylated (activated) forms of the SAPK/JNK kinase, namely P-SAPK/JNK, was performed ( Fig.  2A) . Each experiment included a series of control cultures not subjected to any drugs.
Determination of Cell Apoptosis by Terminal Deoxynucleotidyl Transferase dUTP Nick-End Labeling
Cell apoptosis in SVZ cells was evaluated by the terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL), essentially as previously reported [35] . This method is based on the specific activity of TdT, which attaches labeled nucleotides (dUTP) to the 3Ј-OH ends of the DNA generated during apoptotic-induced DNA fragmentation [37] . At the end of each TNF-␣ incubation protocol (48 hours), SVZ cultures were fixed for 30 minutes in 4% paraformaldehyde (PFA) at room temperature, rinsed in 0.15 M phosphate-buffered saline (PBS; containing 137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , pH 7.4), and permeabilized in 0.25% Triton X-100 (Sigma-Aldrich, St. Louis, http://www. sigmaaldrich.com) for 30 minutes at room temperature. Thereafter, SVZ cultures were incubated for 20 minutes in 3% H 2 O 2 and reacted for terminal transferase (0.25 U/l) biotinylated dUTP (6 M) nick-end labeling of fragmented DNA in TdT buffer (pH 7.5) (all from Roche, Basel, Switzerland, http://www.roche-appliedscience.com) for 1 hour 30 minutes at 37°C in a humidified chamber. The enzymatic reaction was stopped by 15 minutes of incubation in 300 mM NaCl (Sigma-Aldrich) and 30 mM sodium citrate (Sigma-Aldrich) buffer. Following an additional rinse in PBS, cultures were incubated for 30 minutes at room temperature with the avidin-biotin-peroxidase complex (1:100; Vector Laboratories, Burlingame, CA, http://www.vectorlabs.com). Peroxidase activity was revealed by the 3,3Ј-diaminobenzidine chromogen (0.025%; SigmaAldrich) intensified with 0.08% NiCl 2 in 30 mM Tris-HCl (pH 7.6) buffer containing 0.003% H 2 O 2 . The cell preparations were then dehydrated in ethanol (70%, 2 minutes; 80%, 2 minutes; 90%, 2 minutes; 95%, 2 minutes; 100%, 2 minutes), cleared in xylene (3 minutes), and mounted using DEPEX mounting medium (SigmaAldrich). Photomicrographs of TUNEL were recorded using a digital camera (Axiocam HRC; Carl Zeiss, Göttingen, Germany, http://www.zeiss.com) adapted to an Axioskop 2 Plus fluorescent microscope (Carl Zeiss).
Cell Proliferation Studies
To investigate the effect of TNF-␣ on cell proliferation, SVZ cells were exposed to 10 M 5-bromo-2Ј-deoxyuridine (BrdU) (SigmaAldrich) for the last 4 hours of each TNF-␣ treatment ( 
Immunocytochemical Staining for Phenotype Discrimination and Cell Signaling
After fixation in 4% PFA for 30 minutes at room temperature, SVZ cells were permeabilized, and nonspecific binding sites were blocked with 0.25% Triton X-100 and 3% BSA dissolved in 0. 
Single-Cell Calcium Imaging
To determine the functional differentiation pattern of SVZ cells, we analyzed the variations of intracellular calcium-free levels ([Ca 2ϩ ] i ) in single cells following stimulation with 50 mM KCl or 100 M histamine (Sigma-Aldrich) [38] . KCl depolarization causes an increase in [Ca 2ϩ ] i in neurons [39] , whereas stimulation with histamine leads to an increase in [Ca 2ϩ ] i in stem/progenitor cells [40] . SVZ cultures were loaded for 40 minutes with 5 M Fura-2/AM (Molecular Probes), 0.1% fatty acid-free BSA, and 0.02% pluronic acid F-127 (Molecular Probes) in Krebs solution (132 mM NaCl, 4 mM KCl, 1.4 mM MgCl 2 , 1 mM CaCl 2 , 6 mM glucose, 10 mM HEPES, pH 7.4), in an incubator with 5% CO 2 and 95% atmospheric air at 37°C. After a 10-minute postloading period at room temperature in the same medium without Fura-2 and pluronic acid, to obtain a complete hydrolysis of the probe, the glass coverslip was mounted on an RC-20 chamber in a PH3 platform (Warner Instruments, Hamden, CT, http://www.warneronline.com) on the stage of an inverted fluorescence microscope (Axiovert 200; Carl Zeiss). Cells were continuously perfused with Krebs solution and stimulated by applying high-potassium Krebs solution (containing 50 mM KCl, isosmotic substitution with NaCl) or 100 M histamine. Solutions were added to the cells by a fast-pressurized (95% air, 5% CO 2 atmosphere) system (AutoMate Scientific, Inc., Berkeley, CA, http://www.autom8.com). The variations of [Ca 2ϩ ] i were evaluated by quantifying the ratio of the fluorescence emitted at 510 nm following alternate excitation (750 milliseconds) at 340 and 380 nm, using a Lambda DG4 apparatus (Sutter Instrument, Novato, CA, http://www.sutter.com) and a 510 nm band-pass filter (Carl Zeiss) before fluorescence acquisition with a ϫ40 objective and a CoolSNAP digital camera (Roper Scientific, Trenton, NJ, http:// www.roperscientific.com). Acquired values were processed using the MetaFluor software (Universal Imaging Corp., West Chester, PA, http://www.moleculardevices.com). Histamine/KCl values for Fura-2 ratio were calculated to determine the extent of neuronal maturation in cultures.
Isolation of Total RNA from SVZ Cells
Total RNA was isolated from SVZ cells and murine spleen cells, using TRI Reagent (Sigma-Aldrich) according to the manufacturer's instructions. Cells were gently homogenized in guanidium thiocyanate and phenol and allowed to stand at room temperature to secure the complete dissociation of nucleoprotein complexes. Chloroform was added, allowing a clear isolation of RNA in the resultant aqueous phase. Then, the RNA was precipitated with isopropanol and the pellet was washed with 75% (vol/vol) ethanol, redissolved in diethylpyrocarbonate-treated water, and stored at Ϫ80°C.
The total amount of RNA was quantified by optical density (OD) measurements at 260 nm, and the purity was evaluated by measuring the ratio of OD at 260 and 280 nm (RNA/DNA calculator GeneQuant II; Amersham, Uppsala, Sweden, http://www. amersham.com). In addition, RNA quality was assessed by gel electrophoresis.
Reverse Transcription-Polymerase Chain Reaction Analysis
mRNA expression of TNFR1 and TNFR2 was determined by reverse transcription (RT)-polymerase chain reaction (PCR). First, cDNA was obtained from the transcription of 2 g of RNA using avian microblastosis virus reverse transcriptase and oligo-p(dT)15 primers (Roche Molecular Biochemicals, Indianapolis, http://www. roche-applied-science.com). PCR was performed in a 50-l reaction system (Roche Molecular Biochemicals) containing 5 l of template cDNA, 1 l of deoxynucleotide mix, 5 l of 10ϫ PCR buffer, 0.2 l of upstream primer, 0.2 l of downstream primer, a variable volume of water, and 0.25 l of DNA-free sensitive Taq DNA polymerase (35 cycles of 95°C for 30 seconds, 53°C/58°C [TNFR1/TNFR2] for 30 seconds, and 72°C for 30 seconds; Bioron GmbH, Ludwigshafen, Germany, http://www.bioron.net). Primers used in PCRs were as follows: TNF-␣ receptor 1, forward primer, 5Ј-CCG GGC CAC CTG GTC CG-3Ј, and reverse primer, 5Ј-CAA GTA GGT TCC TTT GTG-3Ј; TNF-␣ receptor 2, forward primer, 5Ј-CTC GCG CTG TTC GAA CTG-3Ј, and reverse primer, 5Ј-GGT ATA CAT GCT TGC CTC ACA GTC-3Ј (MWG Biotech, Ebersberg, Germany, http://www.mwg-biotech.com) [26] ; and ␤-actin, forward primer, 5Ј-GAC TAC CTC ATG AAG ATC CT-3Ј, and reverse primer, 5Ј-ATC TTG ATC ATG GTG CTG-3Ј (35 cycles of 95°C for 60 seconds, 55°C for 60 seconds, and 72°C for 60 seconds).
PCR products of each sample were subjected to electrophoresis in a 1.5% agarose gel and stained with ethidium bromide. Negative controls were performed without RNA sample, which was replaced by water. Positive controls were total murine spleen mRNA samples. Photographs were taken in a Versa-Doc Imaging System (model 3000; Bio-Rad, Hercules, CA, http://www.bio-rad.com).
Statistical Analysis
In all experiments, measurements were performed in the border of SVZ neurospheres where migrating cells form a cell monolayer. For SCCI experiments, the percentage of neuronal-like responding cells (with a histamine/KCl ratio below 0.8) was calculated on the basis of one microscopic field per coverslip, containing approximately 100 cells (magnification, ϫ40). Percentages of neuronal-like responding cells in untreated control cultures were set to 100%. Each experimental condition was assayed in three different coverslips. Except where otherwise specified, the experiments were replicated in three independent culture preparations. Percentages of NeuN, BrdU, or TUNEL immunoreactive cells in SVZ cell cultures were calculated from cell counts in five independent microscopic fields in each coverslip with a ϫ40 objective (approximately 200 cells per field). Quantification of P-SAPK/JNK positive nuclei per neurosphere (at 15 minutes) was done in two independent culture preparations in at least 20 nonoverlapping fields, using confocal digital images (magnification, ϫ40; LSM 510 Meta; Carl Zeiss). Quantification of the number of neuritic ramifications positive for P-SAPK/JNK per neurosphere, as well as the total neuritic length and growth cone-like structures per neurosphere (at 6 hours), was performed in five independent culture preparations in approximately 20 nonoverlapping fields per coverslip using digital images (magnification, ϫ20). Software used was Axiovision, release 4.6 (Carl Zeiss).
Data are expressed as means Ϯ SE of mean (SEM). Statistical significance was determined by using the unpaired two-tailed Student's t test, with p Ͻ .05 considered to represent statistical significance.
RESULTS

SVZ Cells Express Both TNFR1 and TNFR2
To investigate the expression of both TNFR1 and TNFR2, we performed RT-PCR [26] and immunocytochemistry in SVZ cultures. As shown in Figure 1 , both receptors were detected by RT-PCR analysis (n ϭ 3 for each receptor) (Fig. 1A) and by standard immunocytochemistry in differentiated and undifferentiated SVZ cells (Fig. 1C, 1D , respectively). Positive and negative controls were performed to confirm the specificity of the primers and of the primary antibodies used for the detection of both TNF-␣ receptors. In accordance with the higher levels of TNFR1 compared with TNFR2 detected by either RT-PCR and immunocytochemistry, clear Western blotting bands corresponding to the expression of TNFR1 were detected in SVZ explants and neurospheres (Fig. 1B) .
TNF-␣ Induces Neuronal Differentiation Via TNFR1 Activation
To functionally evaluate neuronal differentiation in SVZ cultures, we established a method based on variations of [Ca 2ϩ ] i in single cells in response to KCl or histamine (Fig. 2B-2D ) [38] . Membrane depolarization of neuronal cells following exposure to high KCl concentrations leads to the opening of voltage sensitive calcium channels and massive influx of calcium into the cytoplasm [39] , whereas stimulation with histamine specifically triggers an increase in [Ca 2ϩ ] i in immature SVZ cells [40] . In view of these findings, we demonstrated that the ratio of responses due to histamine or KCl exposure (Hist/KCl) differs significantly between cell type groups, with a low Hist/KCl ratio (below 0.8) being characteristic of SVZ-derived neurons (Fig.  2C, 2D ) [38] .
Thus, to investigate whether TNF-␣ might influence the capacity of SVZ cells to differentiate into functional neuronal cells, 6 -8-day-old SVZ neurospheres were allowed to develop on poly-D-lysine-coated coverslips for 7 days in the presence of recombinant mouse (1 or 10 ng/ml) or human (1 ng/ml) TNF-␣. Adherence on a poly-D-lysine substrate and withdrawal of growth factors are necessary steps to promote outward cell migration and differentiation of progenitor cells at the border of the neurospheres [41] . At the border of neurospheres, migrating cells emerged, forming a cell monolayer, where all the measurements of [Ca 2ϩ ] i and cell countings of immunostainings were performed. At the end of TNF-␣ treatments, the SVZ cells were loaded with the Fura-2/AM calcium probe, perfused continuously for 15 minutes with Krebs solution, and briefly (2 minutes) stimulated with 50 mM KCl or 100 M histamine, as depicted in Figure 2B .
Interestingly, the majority of TNF-treated SVZ cells displayed an increase in the [Ca 2ϩ ] i in response to KCl but not to histamine stimulation, consistent with a neuronal-like profile (Fig. 3A) . In contrast, control, nontreated cultures showed a predominant immature-like profile, characterized by an increase in [Ca 2ϩ ] i in response to histamine but a small response or no response to KCl stimulation (Fig. 3A) . Quantification of the percentage of cells displaying a low histamine/KCl ratio showed that TNF-␣ induced increases of approximately threefold (308.9% Ϯ 46.52%; 928 cells analyzed; p Ͻ .001) and approximately twofold (203.5% Ϯ 38.9%; 325 cells analyzed; p Ͻ .05) in the proportion of neuronal-like responding SVZ cells, for 1 and 10 ng/ml, respectively, compared with control, nontreated cells (1,930 cells analyzed) (set to 100%) (Fig. 3A) . To determine which receptor mediates the proneurogenic effect of TNF-␣, SVZ cells were coincubated for 7 days with 1 ng/ml TNF-␣ and with neutralizing antibodies to each TNF-␣ receptor. We found that the proneurogenic effect mediated by 1 ng/ml TNF-␣ was inhibited by coincubation with the neutralizing anti-TNFR1 antibody (54.8% Ϯ 34.2%; 288 cells analyzed; p Ͻ .001 vs. 1 ng/ml TNF alone) but not with the neutralizing anti-TNFR2 antibody (368.8% Ϯ 84.3%; 224 cells analyzed) (Fig. 3A) . In agreement, SVZ cultures incubated with human recombinant TNF-␣ (1 ng/ml), known to bind to mouse TNFR1 only [42] , showed an approximately threefold increase (323.2% Ϯ 83.2%; 650 cells analyzed) in the proportion of neuronal-like responding cells, similarly to mouse recombinant TNF-␣ (Fig. 3A) . To disclose a possible effect of endogenous secreted TNF-␣ on SVZ cell differentiation, the cells were treated with an anti-TNF-␣ antibody. Neutralization of endogenous TNF-␣ did not significantly reduce the percentage of neuronal-like cells in the culture (control: 100.0% Ϯ 15.5%, n ϭ 7 coverslips, 528 cells analyzed; anti-TNF-␣ antibody alone: 92.9% Ϯ 35.9%, n ϭ 4 coverslips, 306 cells analyzed; p ϭ .84). Moreover, mouse recombinant TNF-␣ induced increases in NeuN-immunoreactive cells (a neuronal-specific nuclear protein present on mature neurons) to 26% (26.4% Ϯ 1.9%; 2,809 cells counted; p Ͻ .001) and 22% (22.3% Ϯ 3.1%; 4,057 cells counted; p Ͻ .001) for 1 and 10 ng/ml, respectively, compared with 8% NeuN-immunoreactive cells present in control cultures (8.5% Ϯ 1.0%; in 8,446 cells counted). Interestingly, no significant effect was observed in SVZ cells treated with 0.3 or 100 ng/ml TNF-␣ (Fig. 3B) . Immunoreactivity against MAP-2, a microtubule-associated protein present in dendrites of mature neurons, was also increased in SVZ cell cultures treated with both 1 and 10 ng/ml mouse recombinant TNF-␣, compared with the control (Fig. 3C) . TNF-␣ treatment had no effect on the capacity of the cells to differentiate into the glial lineage, as determined by immunostaining for glial fibrillary acidic protein (data not shown). Together, these results show that when exogenously added at 1 and 10 ng/ml, TNF-␣ induces neuronal differentiation in SVZ cells via TNFR1 activation. [38] . Abbreviations: h, hours; Hist, histamine; min, minutes; N, neurosphere; SVZ, subventricular zone; TNF-␣, tumor necrosis factor ␣.
TNF-␣ Modulates Both Cell Proliferation and Survival
To investigate the role of TNF-␣ on cell proliferation and survival, SVZ cell cultures were exposed to TNF-␣ for 48 hours or 7 days, and BrdU and TUNEL staining was performed ( Fig.  2A) . SVZ cells exposed for 48 hours to 1 ng/ml but not to 10 ng/ml TNF-␣ displayed an approximately 1.5-fold increase (6.3% Ϯ 0.6%; n ϭ 6 coverslips; 3,987 cells counted; p Ͻ .05) in the percentage of BrdU-positive cells compared with control cultures (4.1% Ϯ 0.6%; n ϭ 6 coverslips; 4,370 cells counted) (Fig. 4A) . No significant effect on cell proliferation was observed in 0.3 and 100 ng/ml TNF-␣-treated cells (data not shown). Since the cells were grown under differentiation conditions [41] , the proliferative effect mediated by exposure to 1 ng/ml TNF-␣ for 48 hours was not observed following 7 days of incubation (control: 2.3% Ϯ 0.08%; n ϭ 3 coverslips, TNF-␣: 1.9% Ϯ 0.3%; n ϭ 6 coverslips, p Ͼ .05), probably because of a shift from cell proliferation to neuronal differentiation (described below).
Moreover, we also performed TUNEL staining to examine the effects of TNF-␣ on cell apoptosis. Exposure of SVZ cells to 10 and 100 ng/ml TNF-␣ for 48 hours significantly increased the percentage of TUNEL-positive apoptotic cells to 21% (21.1% Ϯ 1.6%; n ϭ 12 coverslips; 6,511 cells counted; p Ͻ .001) and to 25% (25.7% Ϯ 2.9%; n ϭ 8 coverslips; 4,852 cells counted; p Ͻ .001), compared with 13% of apoptotic cells in the control cultures (13.1% Ϯ 1.1%; n ϭ 13 coverslips; 7,909 cells counted) (Fig. 4B) . No significant effect on cell death was ) and Hoechst 33342 staining (blue nuclei) in a control culture and in cultures exposed to 1 or 10 ng/ml TNF for 7 days. Scale bars ϭ 50 m. Abbreviations: Ab, antibody; Hist, histamine; hTNF, human tumor necrosis factor ␣; mTNF, mouse tumor necrosis factor ␣; NeuN, neuronal nuclear protein; TNF, tumor necrosis factor ␣; TNFR, tumor necrosis factor receptor. observed in 0.3 and 1 ng/ml TNF-treated cells (Fig. 4B) . To ascertain that the increase in TUNEL-positive nuclei is consistent with an induction of apoptosis due to the incubation with 10 ng/ml TNF-␣, SVZ cells were coincubated with TNF-␣ and 25 M zVAD-fmk, a proapoptotic caspase inhibitor. As expected, zVAD-fmk alone inhibited the basal cell apoptosis inherent in control cultures (5.1% Ϯ 0.9%; n ϭ 3 coverslips; 2,234 cells counted; p Ͻ .01 vs. control; the zVAD-fmk solution vehicle, dimethyl sulfoxide, was without effect). Moreover, the toxic effect mediated by 10 ng/ml TNF-␣ was inhibited when SVZ cells were coincubated with 25 M zVAD-fmk (7.2% Ϯ 0.6%; n ϭ 6 coverslips; 4,193 cells counted; p Ͻ .001 vs. 10 ng/ml TNF alone and p Ͻ .01 vs. control) (Fig. 4B) . Taken together, these results suggest that 1 ng/ml TNF-␣ induces cell proliferation, whereas at high concentrations (10 and 100 ng/ml) TNF-␣ triggers cell apoptosis.
TNF-␣ Activates the SAPK/JNK Pathway in -Positive Axons
Several studies have shown that MAP kinase pathways, in particular the SAPK/JNK pathway, play a key role in the signaling transduction of TNF-␣ [43, 44] . To investigate whether the SAPK/ JNK signaling pathway was activated by TNF-␣, SVZ cell cultures were exposed to TNF-␣ for 15 minutes or 6 hours ( Fig. 2A) . At the end of each treatment, immunocytochemistry against the phosphorylated (activated) forms of the JNK kinase (i.e., P-SAPK/JNK) was performed using an antibody that specifically detects endogenous levels of p46 and p54 of the three JNK isoforms (i.e., JNK1, JNK2, and JNK3). Exposure of SVZ cell cultures to 1 or 10 ng/ml TNF-␣ for 15 minutes induced an increase in P-SAPK/JNK-positive nuclei per neurosphere (1 ng/ml TNF, 26.7 Ϯ 2.7, n ϭ 3 coverslips, p Ͻ .001; 10 ng/ml TNF, 33.2 Ϯ 4.7, n ϭ 2 coverslips, p Ͻ .05) compared with control cultures (1.5 Ϯ 0.3; n ϭ 2 coverslips) (Fig.  5A, top row) . Interestingly, exposure of SVZ cells to 1 or 10 ng/ml TNF-␣ for 6 hours (but not for 15 minutes) induced a robust P-SAPK/JNK immunoreactivity in growth cone-like projections and in neurites emerging from the neurospheres and not in the nucleus (Fig. 5A, middle row) . Control cultures showed a diffuse or faint P-SAPK/JNK staining throughout the cytoplasm, with only a few positive growth cone-like structures immunoreactive to P-SAPK/JNK and little or no nuclear localization of P-SAPK/JNK (Fig. 5A, top and middle rows) . Moreover, quantification of the number of ramifications per neurosphere, as well as the total length of ramifications and growth cone-like projections/neurites per neurosphere, showed that 1 ng/ml TNF-␣ induced an approximately fourfold increase in both parameters, compared with control, nontreated cultures (Fig. 5A, bar graphs) . This effect was lost at 100 ng/ml concentration. All the measurements were performed at the border of neurospheres, where the P-SAPK/JNK-immunoreactive fibers emerge. To investigate whether P-SAPK/JNK immunoreactivity was associated with axons, double immunocytochemistry against P-SAPK/JNK and , a microtubule-associated protein that induces bundling and stabilization of axonal microtubules, was performed. As shown in Figure 5B , P-SAPK/JNK immunoreactivity, induced by exposure of SVZ cells to 1 and 10 ng/ml TNF-␣ for 6 hours, was localized in -positive axons. Together, these data suggest that low concentrations (1 ng/ml) of TNF-␣ promote axonogenesis and neuronal maturation of SVZ cell cultures.
DISCUSSION
The major finding of the present work is that TNF-␣, specially at a concentration of 1 ng/ml, induces neurogenesis in mouse SVZ cell cultures, suggesting that some inflammatory mediators may promote brain repair following injury. We observed that 1 and 10 ng/ml TNF-␣ induced an increase in the percentage of cells with a neuronal-like profile (Hist/KCl below 0.8), thus responding more to KCl and less to histamine compared with the control, nontreated cultures. Moreover, TNF-␣ induced an increase in the percentage of NeuN-positive neurons, as well as the immunoreactivity to the neuronal marker MAP-2. Our data suggest that the proneurogenic effect mediated by TNF-␣ involves the activation of the TNFR1, since exposure of SVZ cells to human TNF-␣ induced an increase in the percentage of cells with a neuronal-like profile, similar to the percentage increase mediated by mouse recombinant TNF-␣ and neutralizing antibodies to TNFR1, but not TNFR2, inhibited the proneurogenic effect mediated by 1 ng/ml TNF-␣. Nevertheless, we cannot exclude a possible involvement of the TNFR2 in other effects, such as survival and proliferation. To date, studies on the effects of TNF-␣ on neural stem/progenitor cells have yielded conflicting results. Only a few reports have shown a proneurogenic effect mediated by TNF-␣, although this effect was associated with AIDS dementia and not directly with brain repair [33, 34] . Moreover, other members of the TNF receptors family, such as p75 and Fas, can be also involved in nonapoptotic pathways, such as neurite outgrowth and regeneration [45, 46] .
Using a BrdU incorporation assay, our results provide evidence that TNF-␣ positively regulates proliferation in SVZ cells treated with 1 ng/ml but not those treated with 10 ng/ml TNF-␣. In line with our results, it was reported by others that endoge- nous TNF-␣ promotes proliferation of oligodendrocyte progenitors in a mouse model of demyelination [32] , as well as proliferation of neural progenitors residing in the SVZ/ventricular zone following TNF-␣ injection into the lateral ventricle of adult rat [30] . Thus, TNF-␣ is involved in regulating the turnover of neural stem/progenitor cells.
Because of the presence of the intracellular regions called death domains in the TNFR1, we hypothesize that high TNF-␣ concentrations could induce cell death. Thus, as assessed by TUNEL, 10 and 100 ng/ml TNF-␣, but not 0.3 and 1 ng/ml TNF-␣, induced cell death compared with the control cultures. These results suggest that TNF-␣ at lower concentrations (0.3 and 1 ng/ml) does not reach a Representative fluorescent confocal photomicrographs of the P-SAPK/JNK (green), (red), and Hoechst 33342 (blue) staining in control cultures and in cultures exposed to 1 or 10 ng/ml TNF for 6 h. Scale bars ϭ 20 m. Arrows depict P-SAPK/JNK and double labeling. Abbreviations: h, hours; min, minutes; TNF, tumor necrosis factor ␣.
threshold for activation of death domains; an alternative, but not mutually exclusive, scenario is that TNF-␣ may activate other downstream signaling pathways that do not necessarily induce cell death, depending on cell phenotype/differentiation. Accordingly, Cacci et al. [26] showed that TNF-␣ released from activated microglia, as well as exogenous added TNF-␣, at high concentrations (20 ng/ml), can promote the death of newly formed hippocampal progenitors in vitro [26] . Interestingly, and in accordance with our data, it was also reported that TNF-␣ (10 ng/ml) was cytotoxic to SVZ neurospheres from adult mice [29] .
To investigate the involvement of the SAPK/JNK pathway in response to TNF-␣, we performed immunocytochemistry using specific antibodies against the phosphorylated forms of SAPK/JNK kinase. We observed that TNF-␣ induced a robust change, in a time-dependent manner, of the subcellular localization of the activated (phosphorylated) forms of JNK, in SVZ cultures. After 15 minutes of incubation of SVZ cells with 1 and 10 ng/ml TNF-␣, we observed P-SAPK/JNK immunoreactivity translocation into the nucleus in a significant number of SVZ cells. However, after 6 hours of incubation at both TNF-␣ concentrations, a robust P-SAPK/JNK immunoreactivity was observed on -positive axons and growth cone-like structures extending out of neurospheres, but not in the nucleus. Moreover, TNF-␣ treatment increased the total length and the number of P-SAPK/JNK-positive ramifications. SAPK/JNK kinases are strongly activated in response to cytokines and stress stimuli [47, 48] . In our model, JNK is initially activated following TNF-␣ exposure and translocates to the nucleus, where it can phosphorylate and activate several transcription factors, including c-Jun [49 -51] . Activation of the JNK pathway has been associated with response to a diversity of stresses, and proapoptotic mechanisms [44] . Indeed, c-jun has been shown to transduce cell death signals [52] [53] [54] . However, the JNK pathway appears to mediate both proapoptotic and antiapoptotic functions, depending on the cell type, nature of stimulus, and strength of its activation [55] . Indeed, a growing body of literature supports a role of JNK in cell proliferation, survival, and differentiation [54 -56] . It was shown that the JNK1 gene is involved in the repression of Wnt expression (Wnt is a known inhibitor of embryonic stem [ES] cell neurogenesis) and thus promotes neural differentiation of murine ES cells [57] . Also, disruption of the JNK pathway-specific scaffold protein JSAP1 in murine ES cells reduced neurogenesis in vitro [58] . Moreover, in differentiated neurons from wild-type embryoid bodies, JSAP1 was localized in the soma, neurites, and growth cone-like structures, and neurite outgrowth from the JSAP1-null embryoid bodies was apparently less prominent [58] . Recently, Kim et al. showed that interferon-␥ promotes neuronal differentiation characterized by neurite outgrowth and expression of neuronal markers of a neural progenitor cell line via the JNK pathway [59] . These reports are in agreement with our results showing that after 6 hours of incubation with TNF-␣, P-SAPK/ JNK immunoreactivity is found in -positive axons and growth cone-like structures. Accordingly, 1 ng/ml TNF-␣ promotes both differentiation and maturation. Indeed, the increase in the number of NeuN-positive neurons following TNF-␣ treatment for 7 days (Fig. 3B) suggests an increase in neuronal commitment of progenitors. Moreover, SVZ cultures treated for 6 hours with TNF-␣ display a robust increase in P-JNK immunoreactivity in -positive axons, consistently with neuronal maturation of neuroblasts. P-JNK immunoreactivity is closely associated with new differentiating axons (-positive) and is not associated with fully differentiated neurons. Thus, activated JNK also targets nonnuclear substrates, such as cytoskeletal proteins, neurofilaments, and actin, and so can modify cytoskeletal regulation, cell motility, axonogenesis, and neuronal polarization [60 -66] .
In the intact brain, concentrations of TNF-␣ are low or barely detectable [67] . In accordance, in our experimental conditions, we were not able to find any effect of TNF-␣ at a 0.3 ng/ml concentration on cell proliferation and differentiation. Furthermore, in SCCI studies, we incubated SVZ for 7 days with a neutralizing anti-TNF-␣ antibody to neutralize the biological effects of endogenously produced TNF-␣. Here again, levels of functional differentiation were similar to control levels, demonstrating that at physiological (i.e., low) levels, TNF-␣ modulates SVZ dynamics poorly. However, following brain injury or infection, circulating levels of TNF-␣ dramatically increase to levels close to the range of concentrations that we used in the present study (1-100 ng/ml) [67, 68] . This suggests that these concentrations are of robust pathophysiological relevance, and so TNF-␣ modulates neurogenesis mainly following brain injury and may be part of the repertoire of repairing factors released in the microenvironment that promote neuronal replacement from the SVZ pool of stem/progenitor cells.
CONCLUSION
The proneurogenic effect of TNF-␣ may open new perspectives for brain repair, highlighting the role of proinflammatory cytokines in neurogenesis and neuronal replacement in the damaged brain. We are currently conducting new studies in which SVZ neurospheres pretreated with 1 ng/ml TNF-␣ are transplanted into the hippocampal CA3 subfield in a rodent model of temporal lobe epilepsy. Our preliminary results (data not shown) reveal that TNF-␣-treated SVZ cells differentiate to some extent to doublecortin-positive neuroblasts. Thus, a better understanding of the effects of inflammatory conditions after brain injury or infection in neural stem cells, as well as a better knowledge of the signal transduction pathways activated in neurogenic and inflammatory conditions, will allow the development of new strategies to enhance neuronal differentiation and replacement using SVZ stem cells.
